← Evidence map

ArticleAmerican journal of translational research2022

Efficacy of epalrestat combined with alprostadil for diabetic nephropathy and its impacts on renal fibrosis and related factors of inflammation and oxidative stress.

Yanan Zhou et al.PubMed ↗Full text ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35702110